Moody Aldrich Partners’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-62,245
Closed -$1.62M 189
2020
Q4
$1.62M Sell
62,245
-38,854
-38% -$1.16M 0.26% 97
2020
Q3
$3.76M Sell
101,099
-2
-0% -$79 0.79% 58
2020
Q2
$5.19M Buy
101,101
+12,341
+14% +$516K 1.1% 35
2020
Q1
$2.8M Sell
88,760
-35,471
-29% -$1.87M 0.84% 48
2019
Q4
$7.41M Buy
+124,231
New +$5.59M 1.52% 12
2018
Q2
Sell
-22,478
Closed -$1.63M 101
2018
Q1
$1.63M Buy
22,478
+11,151
+98% +$819K 1.04% 51
2017
Q4
$746K Buy
11,327
+2,347
+26% +$126K 0.6% 76
2017
Q3
$450K Sell
8,980
-2,355
-21% -$114K 0.46% 81
2017
Q2
$525K Buy
+11,335
New +$417K 0.65% 73

Other funds holding ESPR